CME Group Inc. Reports Third-Quarter 2022 Financial Results
CME Group reported strong Q3 2022 financial results, with $1.2 billion in revenue and $680 million net income, translating to $1.87 diluted EPS. Adjusted net income stood at $719 million with adjusted EPS of $1.98. The surge in performance was driven by a 26% increase in trading volume, particularly in interest rates, equity indexes, and foreign exchange. The company returned $363 million to shareholders in dividends this quarter, totaling over $18.8 billion in dividends since 2012.
- Revenue of $1.2 billion, up 26% year-over-year.
- Net income of $680 million with diluted EPS of $1.87.
- Strong demand with year-to-date volumes up 22%.
- Returned $363 million to shareholders in Q3 2022.
- None.
CHICAGO, Oct. 26, 2022 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2022.
The company reported revenue of
"Our strong Q3 financial performance was driven by a
Third-quarter 2022 average daily volume (ADV) was 22.4 million contracts, including non-U.S. ADV of 6.1 million contracts, led by
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials. |
Clearing and transaction fees revenue for third-quarter 2022 totaled
As of September 30, 2022, the company had approximately
CME Group will hold a Q&A conference call to discuss third-quarter 2022 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at www.cmegroup.com. An archived recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data - empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other trademarks are the property of their respective owners.
Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services, including our ability to provide effective services to the swaps market; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; the impact of the COVID-19 pandemic and response by governments and other third parties; our ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with our investment in S&P/Dow Jones Indices LLC (S&P/DJI), our OSTTRA joint venture with IHS Markit (now a part of S&P Global) and our partnership with Google Cloud; uncertainty related to the transition from LIBOR; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry and customer consolidation; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the Securities and Exchange Commission ("SEC") on February 25, 2022, under the caption "Risk Factors".
CME Group Inc. and Subsidiaries Consolidated Balance Sheets (in millions) | ||||
September 30, 2022 | December 31, 2021 | |||
ASSETS | ||||
Current Assets: | ||||
Cash and cash equivalents | $ 2,130.1 | $ 2,834.9 | ||
Marketable securities | 91.3 | 115.0 | ||
Accounts receivable, net of allowance | 580.2 | 434.5 | ||
Other current assets (includes | 476.4 | 427.8 | ||
Performance bonds and guaranty fund contributions | 139,974.9 | 157,949.6 | ||
Total current assets | 143,252.9 | 161,761.8 | ||
Property, net of accumulated depreciation and amortization | 465.5 | 505.3 | ||
Intangible assets—trading products | 17,175.3 | 17,175.3 | ||
Intangible assets—other, net | 3,302.2 | 3,532.0 | ||
Goodwill | 10,447.3 | 10,528.0 | ||
Other assets (includes | 3,788.3 | 3,277.9 | ||
Total Assets | $ 178,431.5 | $ 196,780.3 | ||
LIABILITIES AND EQUITY | ||||
Current Liabilities: | ||||
Accounts payable | $ 95.0 | $ 48.8 | ||
Short-term debt | 14.5 | 749.4 | ||
Other current liabilities | 488.3 | 1,650.6 | ||
Performance bonds and guaranty fund contributions | 139,974.9 | 157,949.6 | ||
Total current liabilities | 140,572.7 | 160,398.4 | ||
Long-term debt | 3,421.8 | 2,695.7 | ||
Deferred income tax liabilities, net | 5,351.5 | 5,390.4 | ||
Other liabilities | 834.7 | 896.5 | ||
Total Liabilities | 150,180.7 | 169,381.0 | ||
Total CME Group Shareholders' Equity | 28,250.8 | 27,399.3 | ||
Total Liabilities and Equity | $ 178,431.5 | $ 196,780.3 | ||
CME Group Inc. and Subsidiaries Consolidated Statements of Income (dollars in millions, except per share amounts; shares in thousands) | ||||||||
Quarter Ended September 30, | Nine Months Ended, September 30, | |||||||
2022 | 2021 | 2022 | 2021 | |||||
Revenues | ||||||||
Clearing and transaction fees | $ 998.6 | $ 878.9 | $ 3,161.3 | $ 2,815.8 | ||||
Market data and information services | 154.3 | 145.4 | 457.7 | 434.8 | ||||
Other | 74.9 | 85.6 | 192.6 | 291.8 | ||||
Total Revenues | 1,227.8 | 1,109.9 | 3,811.6 | 3,542.4 | ||||
Expenses | ||||||||
Compensation and benefits | 189.6 | 198.6 | 560.1 | 635.3 | ||||
Technology | 46.8 | 49.3 | 138.6 | 146.8 | ||||
Professional fees and outside services | 35.1 | 45.2 | 98.9 | 119.4 | ||||
Amortization of purchased intangibles | 55.5 | 59.0 | 171.0 | 179.0 | ||||
Depreciation and amortization | 34.5 | 37.2 | 101.0 | 111.9 | ||||
Licensing and other fee agreements | 83.6 | 57.6 | 247.6 | 176.5 | ||||
Other | 43.9 | 49.3 | 146.8 | 160.0 | ||||
Total Expenses | 489.0 | 496.2 | 1,464.0 | 1,528.9 | ||||
Operating Income | 738.8 | 613.7 | 2,347.6 | 2,013.5 | ||||
Non-Operating Income (Expense) | ||||||||
Investment income | 686.2 | 145.8 | 1,046.2 | 239.1 | ||||
Interest and other borrowing costs | (40.4) | (41.8) | (122.8) | (125.0) | ||||
Equity in net earnings of unconsolidated subsidiaries | 76.5 | 66.4 | 237.1 | 178.3 | ||||
Other non-operating income (expense) | (581.1) | 311.8 | (845.1) | 268.4 | ||||
Total Non-Operating Income (Expense) | 141.2 | 482.2 | 315.4 | 560.8 | ||||
Income before Income Taxes | 880.0 | 1,095.9 | 2,663.0 | 2,574.3 | ||||
Income tax provision | 200.4 | 169.6 | 609.9 | 562.6 | ||||
Net Income | 679.6 | 926.3 | 2,053.1 | 2,011.7 | ||||
Less: net (income) loss attributable to non-controlling interests | — | 0.2 | — | (0.5) | ||||
Net Income Attributable to CME Group | $ 679.6 | $ 926.5 | $ 2,053.1 | $ 2,011.2 | ||||
Net Income Attributable to Common Shareholders of CME Group | $ 671.1 | $ 926.5 | $ 2,027.2 | $ 2,011.2 | ||||
Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 1.87 | $ 2.59 | $ 5.65 | $ 5.61 | ||||
Diluted | 1.87 | 2.58 | 5.64 | 5.60 | ||||
Weighted Average Number of Common Shares: | ||||||||
Basic | 358,715 | 358,363 | 358,655 | 358,258 | ||||
Diluted | 359,288 | 358,988 | 359,206 | 358,894 | ||||
CME Group Inc. and Subsidiaries Quarterly Operating Statistics | ||||||||||
3Q 2021 | 4Q 2021 | 1Q 2022 | 2Q 2022 | 3Q 2022 | ||||||
Trading Days | 64 | 64 | 62 | 62 | 64 | |||||
Quarterly Average Daily Volume (ADV)(1) CME Group ADV (in thousands) | ||||||||||
Product Line | 3Q 2021 | 4Q 2021 | 1Q 2022 | 2Q 2022 | 3Q 2022 | |||||
Interest rates | 8,111 | 9,805 | 12,484 | 10,630 | 10,357 | |||||
Equity indexes | 5,100 | 5,943 | 7,950 | 7,751 | 7,445 | |||||
Foreign exchange | 776 | 800 | 904 | 950 | 1,091 | |||||
Energy | 2,179 | 2,252 | 2,515 | 1,932 | 1,837 | |||||
Agricultural commodities | 1,141 | 1,216 | 1,474 | 1,308 | 1,208 | |||||
Metals | 480 | 475 | 593 | 484 | 498 | |||||
Total | 17,786 | 20,490 | 25,920 | 23,055 | 22,437 | |||||
Venue | ||||||||||
CME Globex | 16,652 | 19,043 | 24,060 | 21,531 | 21,021 | |||||
Open outcry | 598 | 792 | 1,030 | 725 | 704 | |||||
Privately negotiated | 536 | 656 | 830 | 799 | 711 | |||||
Total | 17,786 | 20,490 | 25,920 | 23,055 | 22,437 | |||||
Quarterly Average Rate Per Contract (RPC)(1) CME Group RPC | ||||||||||
Product Line | 3Q 2021 | 4Q 2021 | 1Q 2022 | 2Q 2022 | 3Q 2022 | |||||
Interest rates | $ 0.483 | $ 0.487 | $ 0.484 | $ 0.493 | $ 0.479 | |||||
Equity indexes | 0.555 | 0.526 | 0.526 | 0.532 | 0.524 | |||||
Foreign exchange | 0.803 | 0.779 | 0.800 | 0.767 | 0.729 | |||||
Energy | 1.127 | 1.111 | 1.124 | 1.171 | 1.140 | |||||
Agricultural commodities | 1.319 | 1.323 | 1.378 | 1.411 | 1.351 | |||||
Metals | 1.463 | 1.452 | 1.482 | 1.506 | 1.520 | |||||
Average RPC | $ 0.677 | $ 0.650 | $ 0.644 | $ 0.647 | $ 0.631 | |||||
1. ADV and RPC includes futures and options on futures only. | ||||||||||
CME Group Inc. and Subsidiaries | ||||||||
Reconciliation of GAAP to non-GAAP Measures | ||||||||
(dollars in millions, except per share amounts; shares in thousands) | ||||||||
Quarter Ended September 30, | Nine Months Ended, September 30, | |||||||
2022 | 2021 | 2022 | 2021 | |||||
Net Income Attributable to CME Group | $ 679.6 | $ 926.5 | $ 2,053.1 | $ 2,011.2 | ||||
Restructuring and severance | — | 6.6 | 10.2 | 25.8 | ||||
Amortization of purchased intangibles(1) | 68.5 | 63.1 | 206.4 | 183.1 | ||||
Strategic transaction-related costs(2) | 1.2 | 18.7 | 3.4 | 36.0 | ||||
Foreign exchange transaction (gains) losses | (10.5) | (3.2) | (23.6) | 0.2 | ||||
Unrealized and realized (gains) losses on investments | (1.1) | (434.5) | (4.6) | (455.5) | ||||
Debt costs related to refinancing | — | — | 7.7 | — | ||||
Realized and unrealized losses on assets | 0.7 | 0.5 | 0.7 | 1.7 | ||||
Litigation matters | — | — | — | (3.1) | ||||
Trading floor enhancements | — | 1.4 | 4.8 | 1.4 | ||||
Income tax effect related to above | (11.3) | (0.8) | (40.1) | (34.1) | ||||
Other income tax items(3) | (8.0) | (3.9) | (16.2) | 37.5 | ||||
Adjusted Net Income Attributable to CME Group | $ 719.1 | $ 574.4 | $ 2,201.8 | $ 1,804.2 | ||||
Adjusted Net Income Attributable to Common Shareholders of CME Group | $ 710.0 | $ 574.4 | $ 2,174.1 | $ 1,804.2 | ||||
Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 1.87 | $ 2.59 | $ 5.65 | $ 5.61 | ||||
Diluted | 1.87 | 2.58 | 5.64 | 5.60 | ||||
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 1.98 | $ 1.60 | $ 6.06 | $ 5.04 | ||||
Diluted | 1.98 | 1.60 | 6.05 | 5.03 | ||||
Weighted Average Number of Common Shares: | ||||||||
Basic | 358,715 | 358,363 | 358,655 | 358,258 | ||||
Diluted | 359,288 | 358,988 | 359,206 | 358,894 | ||||
Preferred shares(4) | 4,584 | — | 4,584 | — | ||||
1. Includes | ||||||||
2. Strategic transaction-related costs primarily include professional fees related to the NEX integration. | ||||||||
3. Other income tax items include benefits recognized for the settlement of various tax audits. | ||||||||
4. Preferred shares have similar rights as common shares without voting rights. | ||||||||
CME-G
View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-third-quarter-2022-financial-results-301659327.html
SOURCE CME Group
FAQ
What were CME Group's Q3 2022 earnings results?
How much did CME Group return to shareholders in Q3 2022?
What drove CME Group's revenue growth in Q3 2022?
What is CME Group's future outlook based on Q3 2022 results?
